ACC.13 | Mar. 9 -11, 2013 | San Francisco, Calif.
ACC.13 Opening Session and Late-Breaking Clinical Trials – Session 300
8–10 a.m. PST (UTC - 8 hours)
PREVAIL: Final Results of Randomized Trial of Left Atrial Appendage Closure Versus Warfarin for Stroke/Thromboembolic Prevention in Patients with Non-Valvular Atrial Fibrillation
David Holmes, MD, Mayo Clinic, Minn.
(Not presented at ACC due to an embargo break)
HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER) niacin/laropiprant 2g Daily Versus Placebo in 25,673 Patients At High Risk Of Occlusive Vascular Events
Prof. Jane Armitage, FRCP, Oxford University, Oxford, England
Presentation slides | Summary slide | Video interview | Video discussion
- Approximately every 34 seconds, an American will experience a coronary event, and approximately every minute, someone will die of one.
- Lifetime risk for developing CVD at age 45 is 2 in 3 for men and 1 in 2 for women.
- This year, about 635,000 Americans will have a new coronary attack, and about 280,000 will have a recurrent attack.
- About 29% of patients with MI are patients with STEMI.
- Average age at first MI is 64.5 years for men and 70.3 years for women.
- The estimated average number of years of life lost because of an MI is 16.6.